BE404102A -

Info

Application number

Other languages

Publication of BE404102A publication Critical patent/BE404102A/fr

238000009434 installation Methods 0.000 claims description 8
238000000034 method Methods 0.000 claims description 6
230000005284 excitation Effects 0.000 claims description 3
238000004804 winding Methods 0.000 description 2
WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1